Skip to content

Effect of the test product in reducing dark spots

A clinical study to assess the effectiveness of ayurvedic product in reduction in dark spots - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064874
Enrollment
55
Registered
2024-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hindustan Unilever Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Healthy females volunteers between 20-45 years of age. 2.Subjects with self perceived dark spot problems. 3.Presence of 2-3 spots on face 4.Volunteer in good health condition as per the medical screening criteria with no disease state or physical condition that the Investigator believes could interfere with the interpretation of the data. 5.Subject free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face. 6.Subject who agree not to use of any other skin lightening product/treatment/soap bar/home remedy on their face during the study period other that the study product provided. 7.Subject who agrees not to carry out bleaching or any other skin care procedures on face during the study 8.Volunteer able to read, understand and sign an appropriate informed consent form indicating her willingness to participate.

Exclusion criteria

Exclusion criteria: 1.Volunteers who participated in a study with face as the target area within 4 weeks of the start of this study or is currently participating in such a study. 2.Volunteer pregnant or planning to become pregnant. 3.Volunteers who are breastfeeding or having stopped to breastfeed in the past three months. 4.Volunteers with any other signs of significant local irritation, erythema or skin disease on face as well as on the visible parts of the body skin site. 5.Volunteers with self-perceived sensitive skin. 6.Volunteers having chronic illness or had major surgery in the last year. 7.Volunteers undergoing any treatment of any skin condition on body. 8.Volunteers taking any oral antibiotic medication currently or within the last 8 weeks. 9.Volunteers taking medication 10.Volunteers taking medication for any condition which the Investigator believes may influence the interpretation of the data. 11.Volunteers on food supplements.

Design outcomes

Primary

MeasureTime frame
Significant reduction in severity of dark spotsTimepoint: Baseline, 2week, 4 week

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

raji@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026